Sign in Subscribe
COVID-19

Covid-19 Vaccine Coverage Uncertainty: What to Expect this Fall

Strategic Insights

— 3 min read

As the Covid-19 pandemic enters its fall season, the guidance on vaccine eligibility and insurance coverage is increasingly complex. Health and Human Services Secretary Robert F. Kennedy Jr.'s recent announcement has upended the traditional approval and recommendation process, leaving many people unsure about their coverage. The Centers for Disease Control and Prevention (CDC) has narrowed its recommendation for the Covid-19 vaccine, excluding healthy pregnant people and children from 6 months to 17 years old. However, the Moderna and Pfizer-BioNTech vaccines are still approved for adults 19 and older, albeit with restrictions.

Key Takeaways:

  • The CDC's recommendation for the Covid-19 vaccine has narrowed to exclude healthy pregnant people and children from 6 months to 17 years old.
  • Moderna and Pfizer-BioNTech vaccines are still approved for adults 19 and older, but with restrictions.
  • The Biden administration's announcement has created uncertainty about insurance coverage for the Covid-19 vaccine, with some experts predicting that employer plans may not cover certain categories of people.
  • The Advisory Committee on Immunization Practices (ACIP) has not yet voted on Covid-19 vaccine recommendations for this fall, and its next meeting is scheduled for August or September.
  • Employers and insurers can opt to cover the vaccines on their own, but may require people to pay something for it.
  • Health care professionals can help people determine whether they qualify for the shot based on health conditions.
  • Up to 200 million people may qualify for the vaccines because they have health conditions such as asthma or diabetes that increase their risk of severe disease.
  • The "shared clinical decision-making" model allows children to receive the Covid-19 vaccine if a parent wishes and a health care provider recommends it, which should be covered without cost-sharing.
  • The changes may lead to reduced access to the vaccine, as fewer providers may offer it, particularly for pediatric doses.
  • Pharmacists' authority to administer vaccines depends on several factors, including state regulations and the approval or recommendation status of the vaccine.
  • The long-term implications of the changes are uncertain, but medical and public health professionals are concerned that the recommendation changes may further depress the uptake of the Covid-19 vaccine.

Statistics:

  • Up to 200 million people may qualify for the vaccines because they have health conditions such as asthma or diabetes that increase their risk of severe disease [1].
  • The Moderna vaccine's approval is restricted to adults 65 and older, and for people from 6 months through 64 years old who are at increased risk of developing a serious case of Covid-19.
  • The Novavax and Moderna vaccines are also restricted to people 65 or older and those 12 to 64 who have underlying health conditions that put them at higher risk of developing severe Covid-19.
  • The Pfizer-BioNTech vaccine is still approved or authorized for people 6 months of age and older without any restrictions based on risk factors for Covid-19.

Sources:

  • [1] "COVID-19 Vaccine Coverage: What to Expect this Fall," KFF Health News, [https://kffhealthnews.org/news/article/covid-vaccine-confusion-conflicting-federal-policies-fall-recommendations/](https://kffhealthnews.org/news/article/covid-vaccine-confusion-conflicting-federal-policies-fall-recommendations/).
  • "COVID-19 Vaccine Recommendations," Centers for Disease Control and Prevention, [https://www.cdc.gov/covid/vaccines/hcp/imz-schedules/child-adolescent-notes.html](https://www.cdc.gov/covid/vaccines/hcp/imz-schedules/child-adolescent-notes.html).
  • "FactCheck.org: HHS FAQ Distorts Data on COVID-19 Vaccination During Childhood and Pregnancy," FactCheck.org, [https://www.factcheck.org/2025/06/hhs-faq-distorts-data-on-covid-19-vaccination-during-childhood-and-pregnancy/](https://www.factcheck.org/2025/06/hhs-faq-distorts-data-on-covid-19-vaccination-during-childhood-and-pregnancy/).
  • "COVID-19 Vaccine Eligibility," Moderna, [https://feeds.issuerdirect.com/news-release.html?newsid=5090085430616980&symbol=MRNA](https://feeds.issuerdirect.com/news-release.html?newsid=5090085430616980&symbol=MRNA).
  • "Novavax Announces U.S. FDA Approval of Nuvaxovid COVID-19 Vaccine," Novavax, [https://ir.novavax.com/press-releases/2025-05-19-U-S-FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine](https://ir.novavax.com/press-releases/2025-05-19-U-S-FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine).

Read more